v3.25.2
Financial Instruments - Additional Information (Details)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Derivative [Line Items]                
Trade and other receivables $ 350   $ 350   $ 342      
Debt securities interest income     83   62      
Payments to acquire investments in private companies 71 $ 106 75 $ 107        
Net loss on equity method investment 24 44 47 88        
Net (gain) loss on equity and other investments (682) 76 339 449        
Klaviyo, Inc.                
Derivative [Line Items]                
Net (gain) loss on equity and other investments (14) 7 72 23        
Equity Securities Without Readily Determinable Fair Value                
Derivative [Line Items]                
Equity and Other Investments $ 988 $ 683 $ 988 $ 683 $ 717 $ 709 $ 498 $ 505
Call Option | Klaviyo, Inc.                
Derivative [Line Items]                
Option to purchase series B common shares | shares     15,743,174          
Exercise price (in dollars per share) | $ / shares     $ 88.93          
Discount for Lack of Marketability | Klaviyo, Inc.                
Derivative [Line Items]                
Derivative asset, measurement input 0.29   0.29   0.29      
Fair value $ 132   $ 132   $ 204      
Foreign Exchange Forward                
Derivative [Line Items]                
Foreign exchange forward contracts, notional value 550   550   454      
Level 3 | Fair Value, Nonrecurring                
Derivative [Line Items]                
Equity and Other Investments 846   846          
Accrued interest                
Derivative [Line Items]                
Trade and other receivables $ 39   $ 39   $ 19